Atlas Trials

Dosimetry Based PRRT Versus Standard Dose PRRT With Lu-177-DOTATOC in NEN Patients

Clinical trial NCT04917484 · RECRUITING

Trial details

NCT number
NCT04917484
Sponsor
Tine Gregersen, MD
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Neoplasm
Start date
2020-02-01
Primary completion
2025-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.